By a News Reporter-Staff News Editor at Pharma Business Week — According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for “BRYDEON” by James A. Thomas, representing Merck. This application was made available to the public on July 01, 2014 (see also Trademarks).
The serial number for this application is 85867590.
The international trademark goods and services class code for this trademark application is 005.
As submitted by the applicant, this trademark application relates to the following goods and services: Medicines and pharmaceutical preparations for human use, namely, muscle relaxant antagonists.
The owner/registrar information for this application is: James A. Thomas, Merck, 126 E. Lincoln Avenue, Rahway NJ 07065.
Keywords for this news article include: Merck, Trademarks.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC
An Application for the Trademark “BRYDEON” Has Been Filed by Merck
By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for
- 1 min Read
- 07.9.2014
A weekly five-point roundup of critical events in the energy transition and the implications of climate change for business and finance.
I’m pro-renewable energy. But I’m against worshiping any technology and blindly glossing over its drawbacks.
The company is facing tons of issues. But are these temporary or more permanent?
Thanks to the leap AI’s made this past year, you can now clone any voice from a 30-second clip.
Alnylam’s promising research interests include genetic medicines, cardio-metabolic diseases, hepatic infectious diseases and more.
Gold investors, once optimistic, now exhibit caution and are often ’frozen.’
